NCT03337945View on ClinicalTrials.gov

In Vivo Determination of Cytochrome P450 Activities in Patients With Liver Cirrhosis

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 4, 2018

Primary Completion Date

June 30, 2021

Study Completion Date

December 31, 2021

Conditions
Liver Cirrhosis
Interventions
DRUG

"Basel phenotyping cocktail capsule"

"Oral intake of Basel phenotyping cocktail capsule and pharmacokinetics (PK) sampling"

Trial Locations (1)

4031

Ambulantes Studienzentrum, Universitätsspital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT03337945 - In Vivo Determination of Cytochrome P450 Activities in Patients With Liver Cirrhosis | Biotech Hunter | Biotech Hunter